Population
100 Belgium beers
Design
Other
Key result
Analysis of 100 Belgium beers using G12/A1 monoclonal antibodies estimated at least 20 ppm gluten equivalents in 90 beers and found 10 beers to be gluten-free.
Authors
Loading...
Beers may retain immunotoxic gluten peptides; leaves open safe consumption thresholds for celiac patients and needs clinical validation.
The G12/A1 monoclonal antibody method is a practical and specific way to measure potential immunotoxicity of beers for celiac patients.
Comino et al. (2012) studied Celiac disease (n=100). Immunological determination of gliadin 33-mer equivalent peptides was evaluated on Presence of gluten peptides equivalent to gliadin 33-mer. Analysis of 100 Belgium beers using G12/A1 monoclonal antibodies estimated at least 20 ppm gluten equivalents in 90 beers and found 10 beers to be gluten-free.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: